Lixte Biotechnology's Entry into Crypto: A Strategic Move or Speculative Gamble?
-
最新报道：LIXTE Biotechnology Holdings allocates up to 25% of its treasury to cryptocurrencies like Bitcoin as a long-term hedge and potential value driver, amid broader blockchain integration trends in biotech such as DeSci and supply chain management. The move, following a recent $6.5 million capital raise, aims to diversify assets but carries volatility risks for a firm focused on oncology R&D.
下一篇
Bitcoin's $113K Crossroads: A Test of Institutional Faith
- Bitcoin is testing key resistance at $113,000, with a 12% volume surge over two weeks indi...
24小时热点
财联社10月29日电，谷歌表示，将TPUs（产品）视作将会出售的平台，甚至为了竞争也会这样做。谷歌将在云领域加速新的客户部署
币界网消息，财联社10月29日电，谷歌表示，将TPUs（产品 ...
173
热点专题
418154